Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
暂无分享,去创建一个
D. Renlund | M. Bristow | E. Gilbert | D. Taylor | F. Yanowitz | S. Olsen | Olsen Sl | Frank Yanowitz
[1] W. French,et al. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators. , 1994, Circulation.
[2] G. Plotnick,et al. Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial. , 1994, Journal of the American College of Cardiology.
[3] K. Swedberg,et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.
[4] M. Packer,et al. Role of surrogate end points in the evaluation of drugs for heart failure. , 1993, Journal of the American College of Cardiology.
[5] J. Skoularigis,et al. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy. , 1993, Journal of the American College of Cardiology.
[6] D. Renlund,et al. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. , 1991, Circulation.
[7] P. Broadhurst,et al. Value of carvedilol in congestive heart failure secondary to coronary artery disease. , 1990, The American journal of cardiology.
[8] S. G. Pollock,et al. Usefulness of bucindolol in congestive heart failure. , 1990, The American journal of cardiology.
[9] P. Grayburn,et al. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. , 1990, Circulation.
[10] D. Renlund,et al. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. , 1990, The American journal of medicine.
[11] M. Bristow,et al. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. , 1986, Circulation.
[12] M. Sole,et al. Favorable effects of pindolol in dilated cardiomyopathy. , 1986, Chest.
[13] P A Poole-Wilson,et al. Six minute walking test for assessing exercise capacity in chronic heart failure. , 1986, British medical journal.
[14] R. Gunnar,et al. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. , 1985, Circulation.
[15] J. Anderson,et al. A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. , 1985, The American journal of cardiology.
[16] J S Janicki,et al. Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. , 1985, The American journal of cardiology.
[17] R M Gardner,et al. "Anaerobic threshold": problems of determination and validation. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.
[18] M. Laks,et al. Beta-adrenergic receptor and cyclic AMP alterations in the canine ventricular septum during long-term norepinephrine infusion: implications for hypertrophic cardiomyopathy. , 1983, Circulation.
[19] D C Harrison,et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.
[20] L. Horwitz,et al. Attenuation of Exercise Conditioning by Beta‐adrenergic Blockade , 1982, Circulation.
[21] R. A. Johnson,et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. , 1982, The New England journal of medicine.
[22] H. Ikram,et al. DOUBLE-BLIND TRIAL OF CHRONIC ORAL BETA BLOCKADE IN CONGESTIVE CARDIOMYOPATHY , 1981, The Lancet.
[23] K. Swedberg,et al. PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE , 1979, The Lancet.
[24] E. Varnauskas,et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. , 1975, British heart journal.
[25] Copeman Pw,et al. LUNG CANCER AND SMOKING. , 1964, Lancet.
[26] J. Port,et al. Receptor pharmacology of carvedilol in the human heart. , 1992, Journal of cardiovascular pharmacology.
[27] K. Strein,et al. Pharmacological Profile of Carvedilol, a Compound with &bgr;‐Blocking and Vasodilating Properties* , 1987, Journal of cardiovascular pharmacology.
[28] J. Federman,et al. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy. , 1984, Journal of the American College of Cardiology.
[29] T. Levine,et al. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. , 1981, The American journal of cardiology.